Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities
Net loss	$ (347,947)	$ (414,664)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	27,673	2,532
Stock-based compensation	8,906	9,144
Loss on disposal of property and equipment	3,698	1,407
Non-cash change in fair value of related party notes payable and related party warrant liabilities	(5,110)	0
Non-cash change in fair value of notes payable and warrant liabilities	(90,461)	(4,580)
Change in fair value of earnout liability	1,381	0
Change in operating lease right-of-use assets	2,491	2,265
Loss on foreign exchange	218	2,484
Loss on write-off of vendor deposits, net	408	2,992
Non-cash interest expense	0	8,050
Other	1,008	324
Changes in operating assets and liabilities:
Deposits	(19,237)	13,364
Inventory	(30,758)	0
Other current and non-current assets	(3,415)	(10,656)
Accounts payable	13,838	27,467
Accrued payroll and benefits	0	9,372
Accrued expenses and other current liabilities	(23,332)	(21,117)
Operating lease liabilities	(1,838)	(1,226)
Accrued interest expense	(26)	(12,721)
Net cash used in operating activities	(240,370)	(355,109)
Cash flows from investing activities
Payments for property and equipment	(10,846)	(112,099)
Net cash used in investing activities	(10,846)	(112,099)
Cash flows from financing activities
Proceeds from issuance of common stock	8,520	0
Proceeds from exercise of warrants	4,074	1,728
Payments of notes payable	0	(87,258)
Payments of finance lease obligations	(1,016)	(1,410)
Repurchase of Common Stock	0	(767)
Proceeds from exercise of stock options	44	9,535
Net cash provided by (used in) financing activities	237,565	(40,935)
Effect of exchange rate changes on cash and restricted cash	3,704	11,594
Net decrease in cash and restricted cash	(9,947)	(496,549)
Cash and restricted cash, beginning of period	18,514	530,477
Cash and restricted cash, end of period	8,567	33,928
Cash and restricted cash
Cash	6,714
Restricted cash	1,853
Total cash and restricted cash	8,567	33,928
Supplemental disclosure of noncash investing and financing activities
Reclassification of earnout shares from equity to liability on April 21, 2023 due to insufficient authorized shares	2,112	0
Reclassification of stock-based awards from equity to liability on April 21, 2023 due to insufficient authorized shares	2,979	0
Recognition of operating right of use assets and lease liabilities upon adoption of ASC 842 and for new leases entered into in 2022	0	11,906
Additions of property and equipment included in accounts payable and accrued expenses	0	12,056
Issuance of Secured SPA Warrants	34,257	0
Issuance pursuant to commitment to issue registered shares	0	32,900
Receipt of class A common stock in consideration of exercises of options	0	669
Transfer of private warrants to unaffiliated parties	0	186
Conversion of convertible note to equity	0	84,780
Acquisitions of property and equipment included in accounts payable	34,124	0
Issuance of Secured SPA Notes pursuant to the Exchange Agreement (Note 7)	16,500	0
Change in classification of warrants from Additional paid-in capital to liability pursuant to the Warrant Exchange (Note 7)	6,811	0
Reduction in outstanding warrants pursuant to the Exchange Agreement (Note 7)	(16,506)	0
Supplemental disclosure of cash flow information
Cash paid for interest	465	12,721
February 28, 2023
Supplemental disclosure of noncash investing and financing activities
Reclassification of stock-based awards liability to equity due to authorized share increase	8,978	0
Reclassification of earnout shares liability to equity due to authorized share increase	5,014	0
August 25, 2023
Supplemental disclosure of noncash investing and financing activities
Reclassification of stock-based awards liability to equity due to authorized share increase	2,043	0
Reclassification of earnout shares liability to equity due to authorized share increase	1,381	0
Related Party
Supplemental disclosure of noncash investing and financing activities
Conversion of notes payable and accrued interest into Class A Common Stock	11,254	0
Nonrelated Party
Supplemental disclosure of noncash investing and financing activities
Conversion of notes payable and accrued interest into Class A Common Stock	114,073	0
Nonrelated Party
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on settlement of notes payable	204,885	30,454
Cash flows from financing activities
Proceeds from related party notes payable, net of original issuance discount	208,650	40,050
Payment of notes payable issuance costs	(2,489)	(2,813)
Related Party
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on settlement of notes payable	17,248	0
Cash flows from financing activities
Proceeds from related party notes payable, net of original issuance discount	$ 19,782	$ 0